Grow Therapy Launches Measurement-Based Care, Backed by Sequoia

At Grow Therapy, our bold ambition is simple: to make the mental healthcare system work reliably for everyone who gives and receives care. We pursue that goal by building a unified, clinician-first platform that helps therapists manage their practices, enables patients to find and receive high-quality care, and supports payors in delivering better outcomes for their members.

We are excited to announce a new milestone: an $88 million Series C funding round led by Sequoia Capital, with participation from Goldman Sachs Alternatives and PLUS Capital, along with contributions from artists and athletes including Anna Kendrick, Lily Collins, Dak Prescott, Joe Burrow, Jrue Holiday, and Lauren Holiday. These partners were chosen for their experience backing leading technology and healthcare companies and their shared belief in our mission. They join our existing investors Transformation Capital, SignalFire, and TCV.

Our Mission

Everyone should be able to access effective mental healthcare, regardless of background, location, or financial circumstance. Grow Therapy was founded from a personal need: we experienced firsthand how difficult it can be to find reliable, affordable mental health services. That experience continues to guide our work.

We focus on making the challenging and vital work of therapists more sustainable and rewarding. By removing administrative burdens—insurance billing, patient referrals, scheduling, documentation workflows, and peer support—we enable clinicians to concentrate on care. In turn, that increases patients’ ability to find timely, appropriate providers and receive the help they need.

Our Progress

Since founding the company in 2020, Grow Therapy has made measurable progress in expanding access and improving outcomes:

• We have supported more than 12,000 providers from diverse backgrounds; 44% of these clinicians identify as members of the BIPOC community. Our network covers multiple specialties—individual, couples, family, child & adolescent care, and prescribers—and spans 48 states plus Washington, DC.
• We have enabled over 3 million virtual and in-person sessions, with 94% of those sessions billed to insurance, increasing affordability and access for patients.
• Our platform helps deliver industry-leading experience metrics: an average time-to-care of four days, an 85 Net Promoter Score reflecting high satisfaction, and clinically significant symptom reduction—approximately 50% among clients with moderate to severe symptoms.
• We partner with more than 75 insurance payors, serving members covered by commercial plans, Medicaid, and Medicare. Our payor partnerships are customized to meet each payer’s needs and to improve the member experience.

We are humbled by the stories shared by providers and patients who use our platform:

“In the worst mental state I’ve been in for a very long time I stumbled upon Grow Therapy, and I couldn’t be happier. The care and professionalism at the click of a button is more than I could have asked for during a time when getting dressed and going outside was the most difficult task. The convenience and simplicity of Grow to make this care accessible is something I cherish. For many, Grow has saved our lives.” – Grow Patient

“Grow has been incredible for my practice. Since 2023, I’ve only been growing and I’ve gotten to a point now in which I’m simply going deeper with existing clientele while working less, not more. I’m optimizing my impact and deepening my relationship with existing clients.” – Grow Provider

What’s Next?

Expanding access is necessary but not sufficient. Even as access improves, fragmented technology and disconnected workflows make delivering consistent, high-quality care difficult for many clinicians. With this new funding, we will deepen investments across our platform to remove friction, improve clinical outcomes, and scale value-based care across patient populations—particularly historically underserved groups covered by Medicaid and Medicare.

Recent and ongoing investments include:

• An advanced patient-to-provider matching algorithm that more reliably connects patients with clinicians who meet their clinical and logistical needs.
• A comprehensive documentation system with customizable workflows that reduces administrative time and supports clinical consistency.
• Proprietary telehealth infrastructure designed to provide robust, in-session support for both clinicians and patients.
• A best-in-class measurement-informed care system that tracks outcomes and supports continuous improvement.
• An extensive clinical excellence team that promotes evidence-based practices and ongoing professional development.
• Specialty partnerships to ensure patients with complex or specific clinical needs can access appropriate care.
• Value-based care reporting that demonstrates outcomes and cost-effectiveness to payor partners, enabling more sustainable contracting models.

Each of these product initiatives is guided by feedback from the clinicians and patients who use our platform. Their experiences inspire our commitment to build the next generation of mental healthcare technology—tools that improve access, coordination, and clinical effectiveness.

We enter this next chapter with deep gratitude to the clients, providers, payors, prescribers, investors, and our team who make this work possible.

Jake Cooper
CEO & Co-Founder, Grow Therapy